Effect of PCSK9 Inhibitors on Hemostasis in Patients with Isolated Hypercholesterolemia

Background: In addition to reducing plasma lipids, proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors may produce numerous nonlipid-related pleiotropic effects. The purpose of this trial was to determine the efficacy of PCSK9 inhibitors alone in patients with isolated hypercholesterole...

Descripción completa

Detalles Bibliográficos
Autores principales: Basiak, Marcin, Hachula, Marcin, Kosowski, Michal, Okopien, Boguslaw
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9100169/
https://www.ncbi.nlm.nih.gov/pubmed/35566668
http://dx.doi.org/10.3390/jcm11092542

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9100169/
https://www.ncbi.nlm.nih.gov/pubmed/35566668
http://dx.doi.org/10.3390/jcm11092542

Ejemplares similares